نتائج البحث

1

Activities of SB RAS scientific libraries for heritage preservation of Siberian scientists (to the 120th anniversary of T. T. Deulya birth)

المؤلفون: E. M. Kustova, S. M. Barash

المصدر: Proceedings of SPSTL SB RAS. :109-120

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c3e1bd613ef83ea4faf7bff4a663b3a7Test
https://doi.org/10.20913/2618-7575-2021-4-109-120Test

2

دورية أكاديمية

Effect of cerebrolysin on motor function restoration during medical rehabilitation ; Влияние церебролизина на восстановление двигательной функции в процессе медицинской реабилитации

المؤلفون: M. Kustova A., A. Tolmachev P., N. Shamalov A., М. Кустова А., А. Толмачев П., Н. Шамалов А.

المصدر: Neurology, Neuropsychiatry, Psychosomatics; Vol 8, No 2 (2016); 80-86 ; Неврология, нейропсихиатрия, психосоматика; Vol 8, No 2 (2016); 80-86 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2016-2

مصطلحات موضوعية: ischemic stroke, rehabilitation, neuroprotectors, cerebrolysin, CARS study, ишемический инсульт, реабилитация, нейропротекторы, церебролизин, исследование CARS

وصف الملف: application/pdf

العلاقة: https://nnp.ima-press.net/nnp/article/view/613/563Test; Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013 Aug 1;369(5):448-57. doi:10.1056/NEJMra1201534.; Powers WJ, Derdeyn CP, Biller J, et al., on behalf of the American Heart Association Stroke Council. 2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment. A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2015; 46:3020-3035. Stroke. 2015;46:3020-3035 Published online before print June 29, 2015, doi:10.1161/ STR.0000000000000074; Saver JL, Smith EE, Fonarow GC, et al. GWTG- Stroke Steering Committee and Investigators. The «golden hour» and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset. Stroke. 2010 Jul;41(7):1431-9. doi:10.1161/ STROKEAHA.110.583815. Epub 2010 Jun 3.; Zahuranec DB, Majersik JJ. Percentage of acute stroke patients eligible for endovascular treatment. Neurology. 2012 Sep 25;79(13 Suppl 1):S22-5.; Шамалов НА. Проблемы и перспективы реперфузионной терапии при ишемическом инсульте в России. Фарматека. 2015;302(9):14-9. [Shamalov NA. Problems and prospects of reperfusion therapy in ischemic stroke in Russia. Farmateka. 2015;302(9):14-9. (In Russ.)].; O’Collins VE, Macleod MR, Donnan GA, et al. 1,026 experimental treatments in acute stroke. Ann Neurol. 2006 Mar;59(3):467-77. doi:10.1002/ana.20741; Kaur H, Prakash A, Medhi B. Drug therapy in stroke: from preclinical to clinical studies. Pharmacology. 2013;92(5-6):324-34. doi:10.1159/000356320. Epub 2013 Dec 12.; Xu SY, Pan SY. The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy. Med Sci Monit Basic Res. 2013 Jan 28;19:37-45.; Tymianski M. Novel approaches to neuroprotection trials in acute ischemic stroke. Stroke. 2013 Oct;44(10):2942-50. doi:10.1161/ STROKEAHA.113.000731. Epub 2013 Sep 10.; Hossmann KA. The two pathophysiologies of focal brain ischemia: implications for translational stroke research. J Cereb Blood Flow Metab. 2012 Jul;32(7):1310-6. doi:10.1038/jcbfm.2011.186. Epub 2012 Jan 11.; Masliah E, Diez-Tejedor E. The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders. Drugs Today (Barc). 2012 Apr;48 Suppl A:3-24. doi:10.1358/ dot.2012.48(Suppl.A).1739716.; Hartbauer M, Hutter-Paier B, Skofitsch G, Windisch M. Antiapoptotic effects of the peptidergic drug cerebrolysin on primary cultures of embryonic chick cortical neurons. J Neural Transm (Vienna). 2001;108(4):459-73.; Zhang L, Chopp M, Meier DH, et al. Sonic hedgehog signaling pathway mediates cerebrolysin-improved neurological function after stroke. Stroke. 2013 Jul;44(7):1965-72. doi:10.1161/STROKEAHA.111.000831. Epub 2013 May 21.; Gutmann B, Hutter-Paier B, Skofitsch G, et al. In vitro models of brain ischemia: the peptidergic drug cerebrolysin protects cultured chick cortical neurons from cell death. Neurotox Res. 2002 Feb;4(1):59-65. doi:10.1080/ 10298420290007637.; Darsalia V, Heldmann U, Lindvall O, Kokaia Z. Stroke-induced neurogenesis in aged brain. Stroke. 2005 Aug;36(8):1790-5. Epub 2005 Jul 7. doi:10.1161/01. STR.0000173151.36031.be.; Скворцова ВИ, Стаховская ЛВ, Губский ЛВ и др. Рандомизированное двойное слепое плацебоконтролируемое иссле- дование безопасности и эффективности церебролизина для лечения острого ишемиче- ского инсульта. Журнал неврологии и психиатрии им. С.С. Корсакова (Прил. Инсульт). 2004;(S11):51-5. [Skvortsova VI, Stakhovskaya LV, Gubskii LV, et al. A randomized, double-blind, placebocontrolled trial of safety and efficacy of Cerebrolysin for treating acute ischaemic stroke. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova (Suppl. Stroke). 2004;(S11):51-5. (In Russ.)].; Ladurner G, Kalvach P, Moessler H; Cerebrolysin Study Group. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial. J Neural Transm (Vienna). 2005 Mar;112(3):415-28. Epub 2004 Dec 7. doi:10.1007/s00702-004-0248-2.; Ziganshina LE, Abakumova T, Kuchaeva A. Cerebrolysin for acute ischaemic stroke. Cochrane Database Syst Rev. 2010 Apr 14;(4): CD007026. doi:10.1002/14651858. CD007026.pub2.; Lang W, Stadler CH, Poljakovic Z, Fleet D; Lyse Study Group. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke. Int J Stroke. 2013 Feb;8(2):95-104. doi:10.1111/j.1747- 4949.2012.00901.x. Epub 2012 Sep 26.; Heiss WD, Brainin M, Bornstein NM, et al; Cerebrolysin Acute Stroke Treatment in Asia (CASTA) Investigators. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial. Stroke. 2012 Mar;43(3):630-6. doi:10.1161/STROKEAHA.111.628537. Epub 2012 Jan 26.; Muresanu DF, Heiss WD, Hoemberg V, et al. Cerebrolysin and Recovery After Stroke (CARS). A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Stroke. 2016 Jan;47(1):151-9. doi:10.1161/STROKEAHA.115.009416. Epub 2015 Nov 12.; Lyle RC. A performance test for assessment of upper limb function in physical rehabilitation treatment and research. Int J Rehabil Res. 1981;4(4):483-92. doi:10.1097/ 00004356-198112000-00001.; Posteraro L, Formis A, Grassi E, et al. Quality of life and aphasia. Multicentric standardization of a questionnaire. Eura Medicophys. 2006 Sep;42(3):227-30.; Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders. 2nd ed. Philadelphia, PA: Lea & Febiger; 1983.; https://nnp.ima-press.net/nnp/article/view/613Test

الإتاحة: https://doi.org/10.14412/2074-2711-2016-2-80-86Test
https://doi.org/10.14412/2074-2711-2016-2Test
https://doi.org/10.1056/NEJMra1201534Test
https://doi.org/10.1002/ana.20741Test
https://doi.org/10.1159/000356320Test
https://doi.org/10.1038/jcbfm.2011.186Test
https://doi.org/10.1161/STROKEAHA.111.000831Test
https://doi.org/10.1161/01Test
https://doi.org/10.1007/s00702-004-0248-2Test
https://doi.org/10.1002/14651858Test

View record in BASE

3

THE 70-TH ANNIVERSARY OF THE CENTRAL SCIENTIFIC LIBRARY OF THE IRKUTSK SCIENTIFIC CENTER OF THE SB RAS

المؤلفون: E. M. Kustova

المصدر: Proceedings of SPSTL SB RAS. :98-105

مصطلحات موضوعية: Graduate students, business.industry, Library science, Center (algebra and category theory), Electronic media, Electronic database, Information support, Club, business, Library history, Work experience

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6f6d11942df6c693739d8c7a8e828deaTest
https://doi.org/10.20913/2618-7515-2020-1-98-105Test

4

دورية أكاديمية

Factors influencing the efficiency and safety of systemic thrombolysis in patients with ischemic stroke ; Факторы, влияющие на эффективность и безопасность системного тромболизиса у пациентов с ишемическим инсультом

المؤلفون: N. Shamalov A., K. Anisimov V., M. Kustova A., A. Tolmachev P., Н. Шамалов А., К. Анисимов В., М. Кустова А., А. Толмачев П.

المصدر: Neurology, Neuropsychiatry, Psychosomatics; Vol 6, No 3 (2014); 61-68 ; Неврология, нейропсихиатрия, психосоматика; Vol 6, No 3 (2014); 61-68 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2014-3

مصطلحات موضوعية: ischemic stroke, thrombolytic therapy, ишемический инсульт, тромболитическая терапия

وصف الملف: application/pdf

العلاقة: https://nnp.ima-press.net/nnp/article/view/439/428Test; Available from: http://www.eso-stroke.orgTest; Jauch EC, Saver JL, Adams HP Jr, et al.; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947. DOI: http://dx.doi.org/10.1161/STR.0b013e318284056aTest.; Tillet WS, Garner RL. The fibrinolytic activity of hemolytic streptococci. J Exp Med. 1933;58:485–520. DOI: http://dx.doi.org/10.1084/jem.58.4.485Test.; Fletcher AP, Alkjaersig N, Smyrniotis FE, Sherry S. The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy. Trans Assoc Am Phys. 1958;71:287–96.; Del Zoppo GJ, Zeumer H, Harker LA. Thrombolytic therapy in acute stroke: Possibilities and hazards. Stroke. 1986;17:595–607. DOI: http://dx.doi.org/10.1161/01.STR.17.4.595Test.; Ringelstein EB, Zeumer H. The role of continuous-wave Doppler sonography in the diagnosis and management of basilar and vertebral artery occlusions, with special reference to its application during local fibrinolysis. J Neurol. 1982;228:161–70. DOI: http://dx.doi.org/10.1007/BF00313728Test.; Zeumer H, Hacke W, Ringelstein EB. Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease. Am J Neuroradiol. 1983;4(3):401–4.; Solis OJ, Roberson GR, Taveras JM, et al. Cerebral angiography in acute cerebral infarction. Rev Interam Radiol. 1977;2(1):19–25.; Matsuo O, Kosugi T, Mihara H, et al. Retrospective study on the efficacy of using urokinase therapy. Acta Haem Jap. 1979;42:684–8.; Multicentre Acute Stroke Trial – Italy (Mast-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet. 1995 Dec 9;346(8989):1509–14. DOI: http://dx.doi.org/10.1016/S0140Test- 6736(95)92049-8.; Multicentre Acute Stroke Trial – Europe tudy Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med. 1996 Jul 18;335(3):145–50. DOI: http://dx.doi.org/10.1056/NEJM199607183350301Test.; Yasaka M, Chambers BR, Davis SM, Donnan GA. Streptokinase in acute stroke: effect on reperfusion and recanalization. Australian Streptokinase Trial Study Group. Neurology. 1998 Mar;50(3):626–32. DOI: http://dx.doi.org/10.1212/WNL.50.3.626Test.; Seifried E, Tanswell P, Ellbrü ck D, et al. Pharmacokinetics and haemostatic status during consecutive infusions of recombinant tissuetype plasminogen activator in patients with acute myocardial infarction. Thromb Haemostas. 1989;61(3):497–501.; Tanswell P, Tebbe U, Neuhaus K-L, et al. Pharmacokinetics and fibrin specificity of Alteplase during accelerated infusions in acute myocardial infarction. J Am Coll Cardiol. 1992;19:1071–5. DOI: http://dx.doi.org/10.1016/0735-1097Test(92)90297-Z.; Brott TG, Haley EC Jr, Levy DE, et al. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke. 1992;23:632–40. DOI: http://dx.doi.org/10.1161/01.STR.23.5.632Test.; Haley EC Jr, Levy DE, Brott TG, et al. Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91–180 minutes from onset. Stroke. 1992;23:641–5. DOI: http://dx.doi.org/10.1161/01.STR.23.5.641Test.; Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. New Engl J Med. 1995;333(24):1581–7.; Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke the european cooperative acute stroke study (ECASS). JAMA. 1995;274(13):1017–25.; Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352(9136):1245–51.DOI: http://dx.doi.org/10.1016/S0140-6736Test(98)08020-9.; Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999;282:2019–26. DOI: http://dx.doi.orgTest/ 10.1001/jama.282.21.2019.; Hacke W, Kaste M, Bluhmki E, et al.; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–29. DOI:10.1056/NEJMoa0804656.; Sandercock P, Wardlaw JM, Lindley RI, et al.; IST-3 collaborative group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet. 2012;379(9834):2352–63. DOI: http://dx.doi.org/10.1016/S0140Test- 6736(12)60768-5.; Indyk JA, Chen ZL, Tsirka SE, Strickland S. Laminin chain expression suggests that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/plasmin protease cascade during excitotoxic injury. Neuroscience. 2003;116:359–71. DOI: http://dx.doi.org/10.1016/S0306-4522Test(02)00704-2.; Lo EH, Broderick JP, Moscowitz MA. tPA and proteolysis in the neurovascular unit. Stroke. 2004;35(2):354–6. DOI: http://dx.doi.org/10.1161/01.STR.0000115164.80010.8ATest.; Furlan AJ, Eyding D, Albers GW, et al.; DEDAS Investigators. Dose escalation of desmoteplase for acute ischemic stroke (dedas): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006;37:1227–31. DOI: http://dx.doi.org/10.1161Test/ 01.STR.0000217403.66996.6d.; Hacke W, Albers G, Al-Rawi Y., et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS). A phase II MRI – based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36:66–73. DOI: http://dx.doi.org/10.1161/01.STRTest. 0000149938.08731.2c.; Hacke W, Furlan AJ, Al-Rawi Y, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusiondiffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, doubleblind, placebo-controlled study. Lancet Neurol. 2009;8(2):141–50. DOI: http://dx.doi.org/10.1016/S1474-4422Test(08)70267-9.; Kratzschmar J, Haendler B, Langer G, et al. The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundus: cloning and expression. Gene. 1991;105:229–37. DOI: http://dx.doi.org/10.1016/0378-1119Test(91)90155-5.; Lopez-Atalaya JP, Roussel BD, Ali C, et al. Recombinant desmodus rotundus salivary plasminogen activator crosses the blood-brain barrier through a low-density lipoprotein receptorrelated protein-dependent mechanism without exerting neurotoxic effects. Stroke. 2007;38:1036–43. DOI: http://dx.doi.org/10.1161/01Test. STR.0000258100.04923.84.; Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768–74. DOI: http://dx.doi.org/10.1016/S0140-6736Test(04)15692-4.; Bray BD, Campbell J, Cloud GC, et al.; Intercollegiate Stroke Working Party Group. Bigger, Faster? Associations between hospital thrombolysis volume and speed of thrombolysis administration in acute ischemic stroke. Stroke. 2013;44:3129–35. DOI: http://dx.doi.org/10.1161Test/ STROKEAHA.113.001981.; Carlson MD, Leber S, Deveikis J, Silverstein FS. Successful use of rt-PA in pediatric stroke. Neurology. 2001;57:157–8. DOI: http://dx.doi.org/10.1212/WNL.57.1.157Test.; Engelter ST, Bonati LH, Lyrer PA. Intravenous thrombolysis in stroke patients of 80 versus 80 years of age – a systematic review across cohort studies. Age Ageing. 2006;35:572–80. DOI: http://dx.doi.org/10.1093/ageing/afl104Test.; Mateen FJ, Buchan AM, Hill MD; CASES Investigators. Outcomes of thrombolysis for acute ischemic stroke in octogenarians versus nonagenarians. Stroke. 2010;41:1833–5. DOI: http://dx.doi.org/10.1161/STROKEAHATest. 110.586438.; Khaw KT, Barrett-Connor E, Suarez L, Criqui MH. Predictors of stroke associated mortality in the elderly. Stroke. 1984;15:244–8. DOI: http://dx.doi.org/10.1161Test/ 01.STR.15.2.244.; Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischemic stroke. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD000213. DOI:10.1002/14651858.CD000213.pub2.; Anzini A, Niaz A, Durastanti L, et al. Thrombolysis in young patients: the SITSMOST data. Cerebrovasc Dis. 2008;25 (Suppl 2):3.; Putaala J, Metso TM, Metso AJ, et al. Thrombolysis in young adults with ischemic stroke. Stroke. 2009;40:2085–91. DOI: http://dx.doi.org/10.1161Test/ STROKEAHA.108.541185.; Holroyd-Leduc JM, Kapral MK, Austin PC, Tu JV. Sex differences and similarities in the management and outcome of stroke. Stroke. 2000;31:1833–7. DOI: http://dx.doi.org/10.1161/01.STR.31.8.1833Test.; Kapral MK, Fang J, Hill MD, et al.; Investigators of the Registry of the Canadian Stroke Network. Sex differences in stroke care and outcomes: results from the registry of the canadian stroke network. Stroke. 2005;36:809–14. DOI: http://dx.doi.org/10.1161/01.STRTest. 0000157662.09551.e5.; Meseguer E, Mazighi M, Labreuche J, et al. Outcomes of intravenous recombinant tissue plasminogen activator therapy according to gender: a clinical registry study and systematic review. Stroke. 2009;40:2104–10. DOI: http://dx.doi.org/10.1161/STROKEAHATest. 108.546325.; Savitz SI1, Schlaug G, Caplan L, Selim M. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke. 2005;36:1447–51. DOI: http://dx.doi.org/10.1161/01.STRTest. 0000170647.42126.a8.; Kent DM, Price LL, Ringleb P, et al. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke. 2005;36:62–5. DOI: http://dx.doi.org/10.1161/01.STRTest. 0000150515.15576.29.; Fö rster A, Gass A, Kern R, et al. Gender differences in acute ischemic stroke: etiology, stroke patterns and response to thrombolysis. Stroke. 2009;40:2428–32. DOI: http://dx.doi.org/10.1161/STROKEAHA.109.548750Test.; Tafreshi GM, Raman R, Ernstrom K, et al. Gender differences in acute stroke treatment: the University of California San Diego experience. Stroke. 2010;41:1755–7. DOI: http://dx.doi.org/10.1161/STROKEAHATest. 110.584136.; Pessin M, del Zoppo GJ, Estol C. Thtombolytic agents in the treatment of stroke. Clin Neuropharmacol. 1990;13:271–89. DOI: http://dx.doi.org/10.1097/00002826Test- 199008000-00001.; Okada Y, Yamaguchi T, Minematsu K, et al. Hemorrhagic transformation in cerebral embolism. Stroke. 1989;20:598–603. DOI: http://dx.doi.org/10.1161/01.STR.20.5.598Test.; Lodder J, Krijne-Kubat B, Broekman J. Cerebral hemorrhagic infarction at autopsy: cardiac embolic cause and the relationship to the cause of death. Stroke. 1986;17:626–9. DOI: http://dx.doi.org/10.1161/01.STR.17.4.626Test.; Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke. 1997;28:2119–25. DOI: http://dx.doi.org/10.1161/01.STR.28.11.2119Test.; Fiorelly M, Bastianello S, von Kummer R, et al.; ECASS I Study Group. Hemorrhagic transformation within 36 hours of a cerebral infarct. Relationship with early clinical deterioration and 3-month outcome in the ECASS I cohort. Stroke. 1999;30:2280–4. DOI: http://dx.doi.org/10.1161/01.STR.30.11.2280Test.; Molina CA, Alvarez-Sabin J, Montaner J, et al. Thrombolysis-related hemorragic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke. 2002;33;1551–6. DOI: http://dx.doi.org/10.1161/01Test. STR.0000016323.13456.E5.; Neumann-Haefelin T, Hoelig S, Berkefeld J, et al. Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute Stroke. Stroke. 2006;37:2463–6. DOI: http://dx.doi.org/10.1161/01.STR.0000239321.53203.eaTest.; Dubey N, Bakshi R, Wasay M, Dmochowski J. Early computed tomography hypodensity predicts hemorrhage after intravenous tissue plasminogen activator in acute ischemic stroke. J Neuroimaging. 2001;11:184–8. DOI: http://dx.doi.org/10.1111/j.1552Test- 6569.2001.tb00031.x.; Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke. 1997;28:2109–18. DOI: http://dx.doi.org/10.1161/01.STR.28Test. 11.2109.; Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355:1670–4. DOI: http://dx.doi.org/10.1016/S0140Test- 6736(00)02237-6.; Dzialowski I, Hill MD, Coutts SB, et al. Extent of early ischemic changes on computed tomography (ct) before thrombolysis: prognostic value of the Alberta Stroke Program Eearly CT Score in ECASS II. Stroke. 2006;37:973–8. DOI: http://dx.doi.org/10.1161/01Test. STR.0000206215.62441.56.; Lindsberg PJ, Hä ppö lä O, Kallela M, et al. Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment. Neurology. 2006;67:334–6. DOI: http://dx.doi.org/10.1212/01.wnlTest. 0000224759.44743.7d.; Martin-Schild S, Morales MM, Khaja AM, et al. Is the drip-and-ship approach to delivering thrombolysis for acute ischemic stroke safe? J Emerg Med. 2011 Aug;41(2):135–41. DOI:10.1016/j.jemermed.2008.10.018. Epub 2009 Mar 9; Mayer TE, Hamann GF, Brueckmann HJ. Treatment of basilar artery embolism with a mechanical extraction device: necessity of flow reversal. Stroke. 2002;33:2232–5. DOI: http://dx.doi.org/10.1161/01.STRTest. 0000024524.71680.C6.; Hacke W, Zeumer H, Ferbert A, et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke. 1988;19:1216–22. DOI: http://dx.doi.org/10.1161/01Test. STR.19.10.1216.; Brandt T, von Kummer R, Muller-Kuppers M, Hacke W. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke. 1996;27:875–81. DOI: http://dx.doi.org/10.1161/01Test. STR.27.5.875.; Schonewille WJ, Wijman CA, Michel P, et al. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol. 2009;8:724–30. DOI: http://dx.doi.org/10.1016/S1474Test- 4422(09)70173-5.; Martin-Schild S, Morales MM, Khaja AM, et al. Is the drip-and-ship approach to delivering thrombolysis for acute ischemic stroke safe? J Emerg Med. 2009.; Silverman IE, Beland DK, Chhabra J, McCullough LD. The «Drip-and-ship» approach: starting IV t-Pa for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center. Conn Med. 2005;69:613–20.; Pfefferkorn T, Mayer TE, Opherk C, et al. Staged escalation therapy in acute basilar artery occlusion: Intravenous thrombolysis and ondemand consecutive endovascular mechanical thrombectomy: Preliminary experience in 16 patients. Stroke. 2008;39:1496–500. DOI: http://dx.doi.org/10.1161/STROKEAHATest. 107.505123.; Pfefferkorn T, Holtmannspotter M, Schmidt C, et al. Drip, ship, and retrieve: cooperative recanalization therapy in acute basilar artery occlusion. Stroke. 2010;41:722–6. DOI: http://dx.doi.org/10.1161/STROKEAHATest. 109.567552.; https://nnp.ima-press.net/nnp/article/view/439Test

الإتاحة: https://doi.org/10.14412/2074-2711-2014-3-61-68Test
https://doi.org/10.14412/2074-2711-2014-3Test
https://doi.org/10.1161/STR.0b013e318284056aTest
https://doi.org/10.1084/jem.58.4.485Test
https://doi.org/10.1161/01.STR.17.4.595Test
https://doi.org/10.1007/BF00313728Test
https://doi.org/10.1016/S0140Test
https://doi.org/10.1056/NEJM199607183350301Test
https://doi.org/10.1212/WNL.50.3.626Test
https://doi.org/10.1016/0735-1097Test(92)90297-Z

View record in BASE

5

Features of hpv infection HIV-infected pregnant women

المؤلفون: M. Kustova, S. Javoronok, E. Baranovskaya

المصدر: Immunopathology, Allergology, Infectology. :50-56

مصطلحات موضوعية: business.industry, Hiv infected, HPV infection, medicine, virus diseases, medicine.disease, business, Virology, female genital diseases and pregnancy complications

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7308efde7bd5e9919ca8dc921cb80993Test
https://doi.org/10.14427/jipai.2016.1.50Test

6

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

المؤلفون: Scott E Kasner, Balakumar Swaminathan, Pablo Lavados, Mukul Sharma, Keith Muir, Roland Veltkamp, Sebastian F Ameriso, Matthias Endres, Helmi Lutsep, Steven R Messé, J David Spence, Krassen Nedeltechev, Kanjana Perera, Gustavo Santo, Veronica Olavarria, Arne Lindgren, Shrikant Bangdiwala, Ashkan Shoamanesh, Scott D Berkowitz, Hardi Mundl, Stuart J Connolly, Robert G Hart, N Abdelhamid, D Abdul Rahman, M Abdul-Saheb, P Abreu, M Abroskina, F Abu Ahmad, S Accassat, M Acciaresi, A Adami, N Ahmad, F Ahmed, M Alberto Hawkes, F Alemseged, A Ali, R Altavilla, L Alwis, P Amarenco, S Amaro, LE Amaya Sanchez, A Amelia Pinto, SF Ameriso, H Amin, T Amino, AK Amjad, E Anagnostou, G Andersen, C Anderson, DC Anderson, M Andrea Falco, F Andres Mackinnon, D Andreu, M Androulakis, M Angel Gamero, G Angel Saredo, R Angeles Diaz, M Angels Font, S Anticoli, A Arauz, AA Arauz Gongora, P Araya, JF Arenillas Lara, S Arias Rivas, M Arnold, S Augustin, W Avelar, E Azevedo, V Babikian, A Bacellar, K Badalyan, HJ Bae, EM Baez Martinez, H Bagelmann, P Bailey, Z Bak, M Baker, A Balazs, D Baldaranov, I Balogun, T Balueva, Z Bankuti, M Bar, A Baranowska, J Bardutzky, S Barker Trejo, J Barlinn, F Baronnet, C Barroso, M Barteys, T Bartolottiova, A Barulin, M Bas, S Bashir, V Basile, R Bathe-Peters, R Bathula, C Batista, H Batur Caglayan, P Baumgartner, R Bazan, O Bazhenova, M Beaudry, J Beer, Y Behnam, C Beilei, A Beinlich, Y Bejot, A Belkin, OR Benavente, A Benjamin, V Berardi, D Bereczki, SD Berkowitz, J Berlingieri, W Berrios, J Berrouschot, M Bhandari, M Bhargavah, H Bicker, T Bicsak, M Bilik, D Bindila, J Birchenall, L Birnbaum, T Black, D Blacker, D Blacquiere, C Blanc-Labarre, C Blank, B Blazejewska-Hyzorek, S Bloch, E Bodiguel, E Bogdanov, L Boos, L Borcsik, N Bornstein, S Bouly, G Braga, I Bragado, MC Bravi, C Brokalaki, W Brola, R Brouns, D Bruce, J Brzoska-Mizgalska, B Buck, M Buksinska-Lisik, J Burke, M Burn, G Bustamante, L Cabrejo, K Cai, S Cajaraville, M Calejo, D Calvet, J Campillo, E Campos Costa, P Camps, H Can Alaydin, E Candeloro, C Canepa, CG Cantu Brito, M Cappellari, C Carcel, P Cardona Portela, F Cardoso, M Carek, M Carletti, J Carlos Portilla, P Caruso, I Casado-Naranjo, P Castellini, D Castro, F Castro Meira, A Cavallini, N Cayuela Caudevilla, S Cenciarelli, C Cereda, P Cerrone, A Chakrabarti, P Chaloulos-Iakovidis, A Chamorro, D Chandrasena, DI Chang, C Che, J Chembala, J Chen, Z Chen, T Chen, H Chen, X Chen, G Chen, L Chen, S Chen, B Cheripelli, M Chin, E Chiquete Anaya, M Chorazy, H Christensen, T Christensen, L Christian, F Chu, CS Chung, W Clark, R Clarke, S Claverie, E Clemente Agostoni, B Clissold, J Coelho, D Cohen, S Colakoglu, D Collas, R Condurso, SJ Connolly, D Consoli, C Constantin, AB Constantino Silva, L Contardo, A Corlobe, M Correia, C Correia, E Cortijo Garcia, B Coull, S Coutts, S Coveney, P Cras, R Crols, S Crozier, A Csanyi, L Csiba, K Csontos, R Csuha, L Cui, L Cunha, S Curtze, M Czerska, A Czlonkowska, M Czurko, M Czuryszkiewicz, M Dagnino, C Dai, A Daineko, G Dalek, D Damgaard, A Danese, K Dani, V Danku, W Dario Toledo, A Dávalos, A De Havenon, J De Keyser, N De Klippel, J De La Torre, A De Pauw, A De Smedt, R De Torres, MM De Vries Basson, J Dearborn, R Deganutto, M Degeorgia, I Deguchi, A Del Giudice, C Delcourt, R Delgado-Mederos, G Della Marca, B Delpont, S Deltour, DL Demets, M Dennis, J Desai, J Devine, I Dhollander, MT Di Mascio, M Diaconu, F Diaz Otero, J Dietzel, E Diez-Tejedor, N Ding, J Ding, M Diomedi, P Dioszeghy, M Distefano, V Domigo, E Dorodnicov, D Dossi, F Doubal, I Druzenko, P Du, J Du, T Duman, Y Duodu, D Dutta, L Dylewicz, J Eckstein, E Ehrensperger, S Ehrlich, G Einer Allende, B Elena Halac, S Elyas, M Endres, JM Engelbrecht, S Engelter, M Epinat, F Eren, M Esbjornsson, B Escribano, I Escudero, B Esisi, B Essa, M Esterbauer, N Evans, D Eveson, S Fabio, L Fang, S Fanta, M Fares, M Fatar, K Faust, A Favate, F Fazekas, M Federica Denaro, A Fedin, P Felipe Amaya, J Feng, K Ferencova, M Fernanda Gilli, MD Fernandez, PN Fernandez Pirrone, J Fernandez Vera, J Ferrari, A Ferreira, G Ferreira Junior, M Fidler, D Field, T Field, C Figueroa, J Fiksa, A Filipov, A Firstenfeld, L Fisch, U Fischer, M Fisselier, U Fiszer, F Fluri, G Fortea, K Fotherby, A Fraczek, E France, G Freitas, S Frey, M Frick, A Friedman, M Friedrich, G Frisullo, W Fryze, B Fuentes Gimeno, H Fujigasaki, K Fukuyama, A Furlan, G Furlanis, J Furnace, M Gabriel, E Gabriel Reich, RJ Gagliardi, F Galati, E Galli Giqueauk, A Gallina, E Gallinella, J Gallo, S Gangadharan, Y Gao, R Garcia Lopez, A Garcia Pastor, SM Garcia Sanchez, M Garnauf, P Garnier, D Gasecki, K Gasic, K Gasiorek, S Gasser, M Gaugg, M Gebreyohanns, K Gebura, J Geng, M Geniz Clavijo, K Georg Haeusler, R Geran, M Geremek, Z Gerocs, D Ghia, D Giannandrea, F Giatsidis, JA Gien Lopez, A Gil Nunez, L Gimenez, E Giralt, A Glabinski, D Gladstone, M Gliem, M Gluszkiewicz, R Goddeau, E Gogoleva, M Gokce, D Goldemund, K Golikov, A Gomes Neto, M Gomez Schneider, M Gomez-Choco, M Gomis, JF Gongora-Rivera, Y Gonysheva, L Gonzalez, ME Gonzalez Toledo, M Gottschal, I Gozdzik, S Grabowski, S Graf, D Green, D Greer, T Gregorio, S Greisenegger, I Greshnova, M Griebe, M Grzesik, J Guan, S Guarda, A Gueguen, C Guidoux, P Guillermo Povedano, B Guillon, V Guiraudg, G Gunathilagan, N Guryanova, V Gusev, G Gustavo Persi, R Gutiérrez, P Guyler, N Gyuker, V Hachinski, A Hajas, H Hallevi, G Hankey, GJ Hankey, L Hanouskova, L Hao, K Haraguchi, Y Haralur Sreekantaiah, S Haratz, D Hargroves, K Harkness, P Harmel, M Harrasser, RG Hart, M Harvey, R Hasan, Y Hasegawa, A Hassan, M Hattori, A Hatzitolios, M Hauk, T Hayashi, H Hayhoe, VS Hedna, M Heine, V Held, S Hellwig, J Henkner, N Henninger, S Hermans, J Hernandez, D Herrero, M Hervieu-Begue, R Herzig, L Hicken, M Hieber, M Hill, M Hirose, MC Hobeanu, B Hobson, M Hochstetter, J Hoe Heo, M Hoffmann, C Holmstedt, P Hon, KS Hong, Y Honma, A Horev, G Horgan, L Horvath, M Horvath, C Hoyer, D Huang, H Huang, B Huber, J Huhtakangas, M Hussain, S Igarashi, AM Iglesias Mohedano, J Ignacio Tembl, M Impellizzeri, Y Inanc, P Ioli, A Irina Aniculaesei, K Ishida, R Itabashi, H Iversen, A Jagolino, K Jakab, S Jander, H Janka, J Jankovych, J Jansen, L Jasek, M Javier Alet, L Javor, X Jin, P Jing, B Joachim, M Joan Macleod, M Johnson, J Jose Martin, C Joyner, K Judit Szabo, A Jun-Oconnell, R Jura, B Kaczorowska, J Kadlcikova, T Kahles, N Kakaletsis, I Kakuk, K Kalinowska, K Kaminska, C Kaneko, I Kanellos, P Kapeller, K Kapica-Topczewska, O Karasz, M Karlinski, JE Karlsson, K Kasa, E Kashaeva, SE Kasner, M Kaste, J Kasza, A Katalin Iljicsov, M Katsurayama, S Kaur, M Kawanishi, S Kaygorodtseva, K Ke, A Kei, J Keilitz, J Kellner, P Kelly, S Kelly, D Kemlink, M Kerekgyarto, I Keskinarkaus, D Khairutdinova, A Khanna, A Khaw, M Kholopov, C Khoumri, S Kirpicheva, H Kirshner, K Kitagawa, S Kittner, R Kivioja, F Klein, D Kleindorfer, T Kleinig, P Klivenyi, S Knecht, Y Kobayashi, A Kobayashi, M Koch, L Koehler, M Koivu, V Kolianov, I Koltsov, T Kondo, I Konkov, S Kopecky, E Korompoki, J Korpela, K Kosarz-Lanczek, A Koutroubi, K Kovacs, T Kovacs, H Kovacs, K Kowalczyk, M Kowalska, D Krajickova, M Kral, C Krarup Hansen, J Kraska, S Krebs, V Krejci, C Kremer, R Kreuzpointer, M Krzyzanowska, D Kucken, A Kulakowska, J Kunzmann, N Kurenkova, A Kuris, I Kurkowska-Jastrzebska, N Kurtenkova, O Kurushina, G Kusnick, M Kustova, T Kuwashiro, J Kwan Cha, A Lago, M Lagutenko, B Lajos, J Lambeck, C Lamy, A Landolfi, S Lanfranconi, W Lang, LB Lara Lezama, B Lara Rodriguez, T Largo, A Lasek-Bal, L Latte, V Lauer, P Lavados, R Le Bouc, R Leal Cantu, H Lechner, K Lecouturier, S Leder, J Lee, BC Lee, A Leger, E Leira, I Leisse, R Leker, G Lembo, L Lenskaya, J Leyden, G Li, M Li, S Li, J Li, G Liamis, H Liang, Z Liang, N Ligot, H Lin, R Lindert, A Lindgren, M Linna, T Litwin, K Liu, X Liu, L Llull, B Lohninger, M Longoni, C Loomis, D Lopes, M Lopez Fernandez, N Lopez Garza, A Lord, S Louw, R Lovasz, T Lowenkopf, Z Lu, SC Lubke-Detring, R Luder, S Lujan, B Luo, L Lupinogina, G Luschin, H Lutsep, A Lvova, J Ly, G.M. Grosse, H Ma, C Ma, M Machado, C Machado, S Macher, J Machetanz, F Macian-Montoro, E Mackey, A Mackey, G Maclean, J Maestre-Moreno, A Magadan, T Magyar, A Mahagney, A Majid, A Majjhoo, K Makaritsis, J Mandzia, M Mangas Guijarro, D Mangion, E Manios, S Mann, L Manning, C Manno, J Manuel Garcia, V Maqueda, M Mar Castellanos, M Mar Freijo, C Marando, S Marcela Lepera, J Marcos Couto, G Maria Bruera, L Maria Greco, A Maria Lorenzo, S Maria Obmann, A Maria Roa, C Marini, I Marinkovic, G Mario Sumay, C Mario Torres, M Marko, S Markova, H Markus, R Marsh, E Marsili, M Marta Esnaola, J Marta Moreno, J Marti-Fabregas, S Martina Angelocola, P Martínez Sánchez, N Martinez-Majander, S Martins, O Marzelik, S Mastrocola, G Matamala, A Matoltsy, B Matosevic, S Matsumoto, A Maud, G Mauri Cabdevila, Z May, Y Mayasi, A Mayr, T Mazzoli, K Mcarthur, L Mccullough, CE Medina Pech, F Medlin, M Mehdiratta, S Mehta, D Mehta, B Mehta, M Melis, E Melnikova, B Mendez, T Mendonca, JJ Mengual Chirifie, N Menon, A Mensch, E Meseguer, S Messe, K Metcalf, N Meyer, F Michas, N Micheletti, R Mikulik, H Milionis, B Miller, T Milling, C Minelli, J Minhas, M Minns, D Mircea, S Mishra, A Mismas, A Mistri, N Mitrovic, H Miyake, B Modrau, A Moey, C Molina, J Molina, A Molis, J Moller, S Molnar, F Moniche, C Monosi, V Monzani, M Moonis, R Morais, L Morales, A Morales, D Morar-Precup, F Moreton, C Moro, E Morozova, M Morton, T Morvan, E Morvan, T Motko, A Mowla, E Mozhejko, G Muddegowda, O Mudhar, T Mueller, C Muhl, KW Muir, H Mundl, S Munoz, C Murphy, S Murphy, A Murtuzova, T Musuka, J Mutzenbach, M Myint, W Mysliwy, M Naccarato, G Naeije, Y Nagakane, I Natarajan, D Navaratnam, A Nave, B Nazliel, K Nedeltchev, J Nel, H Nell, R Nemeth, L Nemeth, O Neto, K Ng, J Ngeh, L Nicolas Chialvo, T Nieminen, M Nikkanen, J Nikl, M Nikoforova, S Nishino, Y Nishiyama, X Njovane, S Nogawa, F Nombela, B Norrving, K Nosek, B Nowak, E Nowakowska-Sledz, G Ntaios, H Numminen, F Nunez, M Obadia, S Oberndorfer, A Obrezan, J Ochiai, W Oczkowski, MJ O'Donnell, A Odyniec, K Oh, M Ohira, Y Okamoto, M Okpala, S Okubo, L Olah, V Olavarria, J Oleszek, N Onat Demirci, V Ondar, G Ongun, K Ooyama, V Orosz, R Ortiz, G Osseby, E Österlund-Tauriala, C Ovesen, S Ozcekic Demirhan, J Ozdoba-Rot, S Ozturk, E Ozyurt, M Pablo Grecco, G Pablo Povedano, M Paciaroni, C Padiglioni, J Pagola, W Palasik, G Panczel, L Panos, G Papadopoulos, E Papadopoulou, A Papagiannis, V Papavasileiou, M Papina, JR Pardo De Donlebun, V Parisi, JM Park, J Pasten, N Patel, O Pavlik, M Pawelczyk, WF Peacock, H Pei, T Peisker, LF Pena Sedna, A Penn, S Pentek, E Pepper, L Pereira, K Perera, Y Perez, S Perez, P Perez Leguizamon, M Pernicka, R Perry, A Persico, Y Pesant, S Peska, D Peters, G Peters, L Pettigrew, T Phan, S Philippi, T Phinney, F Pico, A Pidal, B Piechowski-Jozwiak, A Pieroni, S Pineiro, V Piras, N Pizova, J Polanco, M Polin, A Polyakov, E Polychronopoulou, A Polymeris, D Popov, A Poppe, P Postorino, C Pozzerese, M Pradhan, L Prats, E Prazdnichkova, B Prendl, M Pretorius, P Profice, S Prokopenko, E Pudov, V Pujol Lereis, G Punzo Bravo, F Purroy, J Qiu, X Qu, V Quenardelle, H Quesada Garcia, L Radrizzani, A Radtke, T Raffelsberger, JM Ramirez Moreno, C Ramos-Estebanez, A Rani, P Rapantova, K Rashed, A Rasheed Nihara, J Rasmussen, L Redondo Robles, M Reif, P Reiner, P Rekova, A Renu, M Repetto, P Reyes, S Reyes Morales, JH Rha, J Ribeiro, S Ricci, C Richard, R Rigual, C Rinaldi, C Riveira Rodriguez, B Rizzato, TG Robinson, A Rocco, M Rodrigues, G Rodriguez, A Rodriguez Campello, F Rodriguez Lucci, M Rodriguez Yanez, C Roesler, C Roffe, R Roine, S Roine, A Roldan, F Romana Pezzella, M Romano, JS Roos, C Rosso, C Rostrup Kruuse, Y Roth, R Roukens, L Roveri, D Rozanski, J Rozniecki, C Rozsa, S Rudilosso, G Ruiz Ares, A Ruiz Franco, G Rum, J Ruuskanen, I Rybinnik, K Ryota, J Saarinen, V Saavedra, C Sabben, A Sabet, D Sagris, J Sahlas, N Sakai, P Salamanca, P Salgado, S Salig, T Salletmayr, M Salnikov, O Samoshkina, Y Samson, D Sanak, M Sànchez Cerón, P Santalucia, M Santamaria Cadavid, P Santiago, G Santo, B Sanz Cuesta, J Sargento, A Sarraj, K Sas, A Sas, O Satoshi, S Satsoglou, N Sattar, S Savitz, C Savopoulos, J Saw, M Sawicka, R Sawyer, T Scandura, N Schillinger, J Schindler, F Schlachetzki, I Schneider, R Schuppner, J Schurig, CJ Schwarzbach, M Sebejova, G Seidel, L Sekaran, D Selcuk, J Selvarajah, A Semerano, J Semjen, D Semushina, S Sen, M Seok Park, J Serena, O Serhat Tokgoz, W Serles, F Serrano, M Sevin, L Seynaeve, S Shah, N Shamalov, T Shang, M Sharma, A Sharrief, M Shazam Hussain, I Shchukin, W Shen, E Shepeleva, I Shinsuke, A Shmonin, A Shoamanesh, A Shuaib, A Shulga, G Sibolt, I Sibon, I Sicilia, M Siebert, E Sieczkowska, C Sila, AA Silva, D Silva, P Silva, Y Silva, M Silvestrini, Z Simony, A Simpkins, B Singh, D Sinha, I Sipos, O Skoda, P Skowron, M Skowronska, B Sliwinska, J Slonkova, A Smolkin, A Smyth, P Sobolewski, A Sobota, SI Sohn, M Soldatov, I Solganov, L Soloveva, E Solovyeva, N Sonntag, P Soors, M Sorgun, C Soriano, D Spence, K Spengos, L Sposato, G Staaf, K Stadler, L Stakhovskaya, K Stamatelopoulos, S Steinert, I Stetkarova, M Stiehm, R Stocker, J Stoinski, A Stoll, G Stotts, A Stumpp, P Sucapane, T Suenaga, X Sun, S Sundararajan, J Sung Kim, H Suzuki, N Svaneborg, G Szasz, W Szczuchniak, S Szczyrba, N Szegedi, A Szekely, Z Szewczyk, G Szilagyi, S Szlufik, K Szoboszlai, L Szpisjak, R Sztajzel, L Sztriha, SE Ta Wil, J Taggeselle, K Takamatsu, M Takao, W Taki, S Takizawa, M Talahma, A Tamayo, J Tan, D Tanne, A Tapanainen, T Tapiola, J Tarasiuk, T Tatlisumak, A Tayal, S Tcvetkova, P Teal, J Tejada Garcia, H Tejada Meza, D Tenora, M Terceno, A Terentiou, S Tezcan, D Thaler, A Thomson, E Thouvenot, M Tiainen, I Timberg, S Timsit, A Tinchon, D Tirschwell, C Togay Isikay, K Tokunaga, M Tolino, C Toloza, G Tomelleri, K Tomoyuki, LM Tomppo, Z Tong, L Tong, D Toni, J Torres, C Tossavainen, G Toth, A Tountopoulou, E Touze, M Tovar, K Toyoda, S Trillo, A Trommer, D Tropepi, D Tryambake, H Tu, S Tuetuencue, R Tumova, O Tumpula, G Turc, A Tutaj, J Tynkkynen, S Uchiyama, U Uchwat, L Uhrinyakova, R Ulku Acar, D Uluduz Ugurlu, X Urra, S Urui, M Usero Ruiz, D Vaclavik, K Vahedi, A Valikovics, J Valpas, P Van Acker, W Van Daele, G Vanderschueren, L Vanina Jure, R Varela, Z Varga, J Varvat, N Varvyanskaya, A Vasco Salgado, P Vasko, L Vass, S Vassilopoulou, I Vastagh, P Vazquez, L Vecsei, R Veltkamp, M Venti, M Verdugo, V Verocai, M Veronica Marroquin, C Veronica Simonsini, T Veverka, M Vigl, A Vila, C Vilar, JA Villanueva Osorio, J Virta, E Vitkova, B Voglsperger, J Volna, PA Von Weitzel-Mudersbach, N Vora, I Voznyuk, A Wach-Klink, A Wacongne, D Walters, Y Wang, J Wang, L Wang, X Wang, W Wang, N Wang, D Wang, H Wang, W Warnack, K Wartenberg, R Waters, M Waters, T Webb, J Weber, G Weiss, K Weissenborn, JI Weitz, B Weller, G Wen, G Weng, P Werner, D Werring, P Wester, W Whiteley, R Whiting, T Wijeratne, C Willems, L Wilson, C Wilson, T Winder, J Windt, A Winkler, A Winska-Tereszkiewicz, A Wisniewska, M Wittayer, A Wlodek, A Wojnarowska-Arendt, M Wolf, V Wolff, C Wolter, A Wong, H Wook Nah, H Worthmann, W Wu, S Wu, S Wunderlich, H Wurzinger, DG Wyse, B Xiao, W Xiaopeng, A Ximenez-Carrillo, L Xiong, Y Xiong, W Xiong, Y Xu, J Xu, Z Xu, B Yalo, T Yamada, M Yamasaki, L Yang, Y Yang, X Yang, Q Yang, B Yang, J Yang, I Yasuhiro, M Yee Lam, C Yegappan, S Yip, E Ylikallio, P Ylikotila, A Yongwon Jin, BW Yoon, Y Yoshida, L Yperzeele, H Yuan, H Yuasa, J Zalewska, C Zanferrari, E Zapata, D Zboznovits, I Zelenka, C Zhang, B Zhang, S Zhang, M Zhang, X Zhang, J Zhang, L Zhao, O Zhirnova, L Zhou, J Zielinska-Turek, I Zinchenko, M Ziomek, A Zitzmann, R Zweifler, J Zwiernik

المساهمون: Yperzeele, Laetitia, NAVIGATE ESUS Investigators

المصدر: The Lancet Neurology
Andersen, G, Damgaard, D, Weitzel, P V & NAVIGATE ESUS Investigators 2018, ' Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial ', Lancet Neurology, vol. 17, no. 12, pp. 1053-1060 . https://doi.org/10.1016/S1474-4422Test(18)30319-3
Department of Medicine Publications

مصطلحات موضوعية: Male, International Cooperation, 030204 cardiovascular system & hematology, antiplatelet therapy, law.invention, Neurology (clinical), ischemic stroke, anticoagulation, Cohort Studies, 0302 clinical medicine, Randomized controlled trial, Rivaroxaban, law, Stroke, education.field_of_study, Aspirin, Anticoagulant, Settore BIO/14, Middle Aged, 3. Good health, Treatment Outcome, N/A, Cardiology, Platelet aggregation inhibitor, Settore MED/26 - Neurologia, Female, medicine.drug, medicine.medical_specialty, medicine.drug_class, MEDLINE, Population, Foramen Ovale, Patent, Subgroup analysis, Article, Statistics, Nonparametric, 03 medical and health sciences, Double-Blind Method, Internal medicine, medicine, Humans, education, Aged, business.industry, medicine.disease, Human medicine, business, 030217 neurology & neurosurgery, Platelet Aggregation Inhibitors, Factor Xa Inhibitors